The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Paratek Pharmaceuticals's share price is $2.23.
Paratek Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $2.99. Hence, Paratek Pharmaceuticals's PS Ratio for today is 0.75.
Warning Sign:
Paratek Pharmaceuticals Inc stock PS Ratio (=0.71) is close to 1-year high of 0.71
The historical rank and industry rank for Paratek Pharmaceuticals's PS Ratio or its related term are showing as below:
PRTK'
s PS Ratio Range Over the Past 10 Years
Min: 0.52 Med: 21.56 Max: 15260
Current: 0.71
During the past 13 years, Paratek Pharmaceuticals's highest PS Ratio was 15260.00. The lowest was 0.52. And the median was 21.56.
PRTK's PS Ratio is not ranked
in the Biotechnology industry.
Industry Median: 8.92
vs PRTK: 0.71
During the past 13 years, Paratek Pharmaceuticals's highest 3-Year average Revenue per Share Growth Rate was 668.60% per year. The lowest was -89.30% per year. And the median was -7.70% per year.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Paratek Pharmaceuticals's PS Ratio
For the Biotechnology subindustry, Paratek Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paratek Pharmaceuticals's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Paratek Pharmaceuticals's PS Ratio distribution charts can be found below:
* The bar in red indicates where Paratek Pharmaceuticals's PS Ratio falls into.
Paratek Pharmaceuticals PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Paratek Pharmaceuticals's Share Price of today is $2.23. Paratek Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.99.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Paratek Pharmaceuticals (NAS:PRTK) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Paratek Pharmaceuticals PS Ratio Related Terms
Thank you for viewing the detailed overview of Paratek Pharmaceuticals's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Paratek Pharmaceuticals (Paratek Pharmaceuticals) Business Description
Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's medical research is based on tetracycline chemistry and biology to create two antibacterials: omadacycline and sarecycline. NUZYRA (Omadacycline) is an antibacterial for skin infections and treatment of community-acquired bacterial pneumonia. SEYSARA (Sarecycline) is designed for use in the treatment of acne and rosacea. Paratek Pharmaceuticals is also involved in research to treat multiple sclerosis, spinal muscular atrophy, and systemic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRTK has been successfully added to your 